Home
Conditions
Chemically-Induced Disorders

Clinical trial condition

Chemically-Induced Disorders

Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.

7,319 public trials 1,008 recruiting studies

Refine in advanced search Browse all conditions

Chemically-Induced Disorders trial results

Completed

Dysfunctional Hemoglobin Pulse Oximetry

NCT03030833

Conditions: Carbon Monoxide Poisoning, Chemically-Induced Disorders, Gas Poisoning, +1 more
Locations: HPPL Duke Univeristy Durham, North Carolina, United States

View Trial Details

Completed

Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper

NCT00374127

Conditions: Chemically-Induced Disorders, Marijuana Abuse, Marijuana Dependence, +2 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels

NCT01588561

Conditions: Chemically-Induced Disorders, Mental Disorders, Nicotine Dependence, +2 more
Locations: Alcohol and Drug Abuse Research Center at McLean Hospital Belmont, Massachusetts, United States

View Trial Details

Completed

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

NCT00617201

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Abuse, +1 more
Locations: Straus Research Building Lexington, Kentucky, United States

View Trial Details

Completed

Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence

NCT01904487

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +2 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

NCT00577408

Conditions: Chemically-Induced Disorders, Heroin Dependence, Mental Disorders, +4 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Study of Mechanisms of Emotion Regulation in Alcohol-abstinent Patients

NCT02881983

Conditions: Alcohol Use Disorder, Alcohol-Related Disorders, Alcoholism, +3 more
Locations: CSAPA Lille, France

CHRU Lille, Fontan2 Lille, France

View Trial Details

Completed

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00516503

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Rush-Copley Cancer Care Center Aurora, Illinois, United States

St. Joseph Medical Center Bloomington, Illinois, United States

View all 165 locations

View Trial Details

Completed

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

NCT01926626

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +5 more
Locations: Duke Center for Smoking Cessation Charlotte, North Carolina, United States

Duke Center forSmoking Cessation Durham, North Carolina, United States

Duke Center for Smoking Cessation Winston-Salem, North Carolina, United States

View Trial Details

Completed

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

NCT01334736

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +5 more
Locations: Johns Hopkins ALIVE Clinic Baltimore, Maryland, United States

View Trial Details

Chemically-Induced Disorders

Chemically-Induced Disorders trial results

Related conditions